MedTrace Logo

Prospective Cohort Observational Study of Placenta Accreta Spectrum Disorders

NCT06021964 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-09-01

No results posted yet for this study

Summary

The incidence of placenta accreta spectrum disorders has shown an increasing trend worldwide due to the increase of cesarean section rate. Research on the outcomes of placenta accreta spectrum disorders primarily relies on retrospective analysis. The aim of this study was to establish a prospective, multicenter cohort in China in order to conduct further investigations on the clinical features, predictive capabilities, diagnostic methods, and pathogenesis of placenta accreta spectrum disorders.

Conditions

  • Placenta Accreta Spectrum Disorders,Previous Cesarean Section

Sponsors & Collaborators

  • Peking University Third Hospital

    collaborator OTHER

  • Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University

    collaborator UNKNOWN

  • Peking Union Medical College Hospital

    collaborator OTHER

  • TONGJI MEDICAL COLLEGE OF HUST

    collaborator UNKNOWN

  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER

  • West China Second University Hospital,Sichuan University / West China women's and children's Hospital

    collaborator UNKNOWN

  • Peking University First Hospital

    collaborator OTHER

  • Guangzhou Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-28
Primary Completion
2025-11-30
Completion
2025-12-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06021964 on ClinicalTrials.gov